Diagnostic accuracy of smear microscopy, mycobacterial culture, and GeneXpert MTB/RIF assay for diagnosis of subclinical tuberculosis: a retrospective multicenter study
Microbiology Spectrum · 2025
DOI: 10.1128/spectrum.01888-24 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Jin Shi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, C…. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Microscopy, Tuberculosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Capital&' Funds for Health Improvement and Research, Beijing Nova Program.
Abstract (Originalsprache)
Subclinical tuberculosis (TB) challenges public health interventions. This retrospective multicenter study aimed to evaluate the diagnostic efficacy of smear microscopy, mycobacterial culture, and GeneXpert MTB/RIF assay (Xpert) for subclinical TB and identify its proportion and risk factors in China. Among 560 participants diagnosed with TB, 309 (55.18%) patients had active TB, and 251 (44.82%) had subclinical TB. For subclinical TB diagnosis, smear microscopy, mycobacterial culture, and Xpert had detection rates of 11.5%, 40.6%, and 40.6%, respectively, which were significantly lower than those for active TB (25.2%, 59.2%, and 63.7% respectively). Conversely, interferon-γ release assays (IGRA) showed similar detection rates for both subclinical (85.7%) and active TB (84.1%). Age groups of 40–60 years and under 40 years, as well as employed individuals had higher risks of subclinical TB. To conclude, about 45% of TB patients were subclinical in our study. Microbiologic tests had lower diagnostic sensitivities for subclinical TB than for active TB, while IGRA positivity rates were comparable between asymptomatic and symptomatic TB patients, highlighting the potential of antigen-specific immune response in the diagnosis of these asymptomatic individuals. Further clinical trials are warranted to investigate the diagnostic flow chart in individuals with subclinical TB. IMPORTANCE Subclinical tuberculosis (TB) poses a major challenge to public health interventions, especially in the wake of the COVID-19 pandemic. However, a substantial proportion of individuals have absence or non-recognized symptoms, which put great pressure on clinical diagnosis. In this study, we conducted a retrospective multicenter study to assess the performance of smear microscopy, mycobacterial culture, and GeneXpert MTB/RIF (Xpert) in diagnosis of subclinical TB. We also aimed to determine the proportion and risk factors of subclinical TB in China in order to accelerate progress towards global milestones and targets for the End TB Strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
- Tuberculosis Laboratory, Shenyang Tenth People's Hospital/Shenyang Chest Hospital, Shenyang, China.
- Department of Tuberculosis, Beijing Center for Disease Prevention and Control, Beijing, China.
- Department of Bacteriology and Immunology, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
ORCID-Profile: Jin Shi, Mengqiu Gao, Yu Pang
Förderung
- The Capital&' Funds for Health Improvement and Research
- Beijing Nova Program
Zitieren
APA
Shi, J., Yu, Y., Li, B., Shang, Y., Yao, C., Ren, W., Li, S., Gao, M., & Pang, Y. (2025). Diagnostic accuracy of smear microscopy, mycobacterial culture, and GeneXpert MTB/RIF assay for diagnosis of subclinical tuberculosis: a retrospective multicenter study. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01888-24
Vancouver
Shi J, Yu Y, Li B, Shang Y, Yao C, Ren W, et al. Diagnostic accuracy of smear microscopy, mycobacterial culture, and GeneXpert MTB/RIF assay for diagnosis of subclinical tuberculosis: a retrospective multicenter study. Microbiology Spectrum. 2025. doi:10.1128/spectrum.01888-24
BibTeX
@article{Shi2025,
author = {Shi, Jin and Yu, Yanhong and Li, Bo and Shang, Yuanyuan and Yao, Cong and Ren, Weicong and Li, Shanshan and Gao, Mengqiu and Pang, Yu},
title = {Diagnostic accuracy of smear microscopy, mycobacterial culture, and GeneXpert MTB/RIF assay for diagnosis of subclinical tuberculosis: a retrospective multicenter study},
journal = {Microbiology Spectrum},
year = {2025},
doi = {10.1128/spectrum.01888-24}
}
EUVIMED